home / stock / adap / adap news


ADAP News and Press, Adaptimmune Therapeutics plc From 10/16/20

Stock Information

Company Name: Adaptimmune Therapeutics plc
Stock Symbol: ADAP
Market: NASDAQ
Website: adaptimmune.com

Menu

ADAP ADAP Quote ADAP Short ADAP News ADAP Articles ADAP Message Board
Get ADAP Alerts

News, Short Squeeze, Breakout and More Instantly...

ADAP - ReWalk Robotics, Aldeyra Therapeutics leads healthcare gainers; Biomerica, Adaptimmune Therapeutics among major losers

Gainers: ReWalk Robotics (RWLK) +18%, Aldeyra Therapeutics (ALDX) +19%, ClearPoint Neuro (CLPT) +15%, ProPhase Labs (PRPH) +12%, Orchard Therapeutics (ORTX) +11%.Losers: Biomerica (BMRA) -20%, Adaptimmune Therapeutics (ADAP) -14%, Ca...

ADAP - Adaptimmune provides complete contents of its SITC Abstract for SURPASS Trial

Adaptimmune Therapeutics (ADAP) has announced early release of the abstract from SURPASS Phase 1 trial with ADPA2M4CD8, a SPEAR T-cell therapy by the Society for the Immunotherapy of Cancer ((SITC)) Conference.Ongoing trial is evaluating safety and efficacy of ADP-A2M4CD8. Prior to ...

ADAP - Adaptimmune Provides Full Contents of its SITC Abstract for the Phase 1 SURPASS Trial

PHILADELPHIA and OXFORDSHIRE, United Kingdom, Oct. 15, 2020 (GLOBE NEWSWIRE) -- Adaptimmune Therapeutics plc (“Adaptimmune”) (Nasdaq: ADAP), a leader in cell therapy to treat cancer is aware of the early release of the abstract entitled “Initial safety, efficacy, and pr...

ADAP - Adaptimmune Therapeutics: Mega Profitability

Spend each day trying to be a little wiser than you were when you woke up. Day by day, and at the end of the day if you live long enough like most people, you will get out of life what you deserve. - Charlie Munger (Warren Buffett's partner) In cancer research, CAR T-cell therapy has bee...

ADAP - Cancer advances ignite broad biotech and specialized ETF surge

In a year dominated by the Covid crisis and the search for a treatment/vaccine, the last week has seen progress in the fight against cancer, and helped send the biotech sector surging. More news on: Gilead Sciences, Inc., Merck & Co., Inc., Immunomedics, Inc., , News on ETFs Read mo...

ADAP - Adaptimmune Therapeutics (ADAP) Investor Presentation - Slideshow

The following slide deck was published by Adaptimmune Therapeutics plc in conjunction with this Read more ...

ADAP - Promising Data from Phase 1 Trial with ADP-A2AFP in Liver Cancer at the International Liver Congress Confirm Safety Profile and Demonstrate Potential Benefit for Patients

PHILADELPHIA and OXFORDSHIRE, United Kingdom, Aug. 28, 2020 (GLOBE NEWSWIRE) -- Adaptimmune Therapeutics plc (“Adaptimmune”)(Nasdaq: ADAP), a leader in cell therapy to treat cancer, presented data from its Phase 1 trial with SPEAR T-cells targeting AFP at the virtual Inte...

ADAP - Enanta Pharma reports encouraging data on HBV and NASH candidates

Data from Enanta Pharmaceuticals' (NASDAQ: ENTA ) development programs for non-alcoholic steatohepatitis (NASH) and hepatitis B virus (HBV) will be virtually  presented at the European Association for the Study of the Liver Annual Meeting. More news on: Enanta Pharmaceuticals, Inc....

ADAP - Stocks To Watch: Spotlight On Palo Alto Networks, Best Buy And Xpeng Motors

Welcome to Seeking Alpha's Stocks to Watch - a preview of key events scheduled for the next week. Follow this account and turn the e-mail alert on to receive this article in your inbox every Saturday morning. A podcast of Stocks to Watch is also available on Sundays on Seeking Alpha , Apple ...

ADAP - Seeking Alpha Catalyst Watch

Volatility watch: Heading into the new week, short interest is on the rise on Royal Bank of Canada (NYSE: RY ) ahead of the bank's earnings report on August 26 and AstraZeneca (NYSE: AZN ) amid COVID-19 developments. Meanwhile, GameStop (NYSE: GME ) is cruising along with an exceedi...

Previous 10 Next 10